Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pollock

Showing results (521-530 of 634) with videos related to

Pageof 64
Sort By:
Interventional Cardiology (London, England)|July 3, 2023
An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi GroupAzfar Zaman, Bernard Prendergast, David Hildick-Smith, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitationAyman Akil, Robert R Bies, Bruce G Pollock, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adultsEric J Lenze, Alison M Goate, Petra Nowotny, et al.
Journal of Clinical Pharmacology|October 21, 2009
Effect of age, weight, and CYP2C19 genotype on escitalopram exposureYuyan Jin, Bruce G Pollock, Ellen Frank, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophreniaJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
JAMA|January 22, 2009
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trialEric J Lenze, Bruce L Rollman, M Katherine Shear, et al.
JAMA|January 19, 1999
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 yearsC F Reynolds, E Frank, J M Perel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Nortriptyline Side Effects During Double-Blind, Randomized, Placebo-Controlled Maintenance Therapy in Older Depressed PatientsCharles F Reynolds, Ellen Frank, James M Perel, et al.
Alzheimer'S Research & Therapy|August 7, 2023
Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer's dementiaHamed Azami, Christoph Zrenner, Heather Brooks, et al.
Pageof 64

Showing results (521-530 of 634) with videos related to

Sort By:
Pageof 64
Interventional Cardiology (London, England)|July 3, 2023
An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi GroupAzfar Zaman, Bernard Prendergast, David Hildick-Smith, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitationAyman Akil, Robert R Bies, Bruce G Pollock, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adultsEric J Lenze, Alison M Goate, Petra Nowotny, et al.
Journal of Clinical Pharmacology|October 21, 2009
Effect of age, weight, and CYP2C19 genotype on escitalopram exposureYuyan Jin, Bruce G Pollock, Ellen Frank, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 22, 2019
Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophreniaJulia Kim, Eric Plitman, Shinichiro Nakajima, et al.
JAMA|January 22, 2009
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trialEric J Lenze, Bruce L Rollman, M Katherine Shear, et al.
JAMA|January 19, 1999
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 yearsC F Reynolds, E Frank, J M Perel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Nortriptyline Side Effects During Double-Blind, Randomized, Placebo-Controlled Maintenance Therapy in Older Depressed PatientsCharles F Reynolds, Ellen Frank, James M Perel, et al.
Alzheimer'S Research & Therapy|August 7, 2023
Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer's dementiaHamed Azami, Christoph Zrenner, Heather Brooks, et al.
Pageof 64